![Frank W. Marcoux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank W. Marcoux
Director Ejecutivo en Portage Glasgow Ltd. .
Cargos activos de Frank W. Marcoux
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Portage Pharma Ltd.
![]() Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Director Técnico/Científico/I+D | 04/06/2013 | - |
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Director/Miembro de la Junta | - | - |
Portage Glasgow Ltd.
![]() Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Director Ejecutivo | - | - |
Historial de carrera de Frank W. Marcoux
Antiguos cargos conocidos de Frank W. Marcoux.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PORTAGE BIOTECH INC. | Director Técnico/Científico/I+D | - | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Canadá | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectorial
Health Technology | 5 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Portage Pharma Ltd.
![]() Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Health Technology |
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Health Technology |
Portage Glasgow Ltd.
![]() Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Health Technology |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
- Bolsa de valores
- Insiders
- Frank W. Marcoux
- Experiencia